Brief: Double Bond Pharmaceutical Says Positive Response For SI-053 From Ethical Committee In Netherlands Has Been Received
16/12/2021 17:03
Dec 16 (Reuters) - Double Bond Pharmaceutical International
AB (publ) DBPHAb.TE :
* POSITIVE RESPONSE FOR SI-053 FROM ETHICAL COMMITTEE IN
NETHERLANDS HAS BEEN RECEIVED
Source text for Eikon: ID:nWkr8pfl9M
Further company coverage: DBPHAb.TE
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Double Bond Pharmaceutical International AB (publ)
See all newsBrief: DBP International AB And Vivo Biopharma LLC Revised Asset Purchase And Collaboration Agreements
Brief: DBP International AB And Vivo Biopharma LLC Enter Into Asset Purchase And Collaboration Agreements To Develop And Commercialize A Novel Glioblastoma Treatment
Brief: DBP And Vivo Enter Into Asset Purchase And Collaboration Agreements To Develop And Commercialize A Novel Glioblastoma Treatment
Brief: Double Bond Pharmaceutical Says Positive Response For SI-053 From Ethical Committee In Netherlands Has Been Received
Brief: Double Bond To Cooperate With Belarus State Medical University